J.M. Carrascosa

1.3k total citations
32 papers, 571 citations indexed

About

J.M. Carrascosa is a scholar working on Immunology, Economics and Econometrics and Dermatology. According to data from OpenAlex, J.M. Carrascosa has authored 32 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 11 papers in Economics and Econometrics and 10 papers in Dermatology. Recurrent topics in J.M. Carrascosa's work include Psoriasis: Treatment and Pathogenesis (22 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Dermatology and Skin Diseases (8 papers). J.M. Carrascosa is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (22 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Dermatology and Skin Diseases (8 papers). J.M. Carrascosa collaborates with scholars based in Spain, United States and Germany. J.M. Carrascosa's co-authors include E. Daudén, Mónica Munera‐Campos, Marta Ferrán, R. Rivera, G. Carretero, J.L. López‐Estebaranz, I. García‐Doval, M. Ribera, P. de la Cueva and X. Bordas and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

J.M. Carrascosa

31 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Carrascosa Spain 15 400 201 121 107 93 32 571
A.L.A. Kuijpers Netherlands 16 482 1.2× 241 1.2× 119 1.0× 89 0.8× 124 1.3× 23 710
X. Bordas Spain 17 594 1.5× 356 1.8× 176 1.5× 132 1.2× 133 1.4× 33 934
Eva Vilarrasa Spain 20 545 1.4× 610 3.0× 121 1.0× 99 0.9× 116 1.2× 50 967
M.A.M. Berends Netherlands 13 379 0.9× 211 1.0× 108 0.9× 82 0.8× 72 0.8× 19 539
J.L. Sánchez‐Carazo Spain 14 268 0.7× 204 1.0× 73 0.6× 94 0.9× 76 0.8× 38 470
Ting‐Shun Wang Taiwan 11 294 0.7× 178 0.9× 80 0.7× 23 0.2× 54 0.6× 18 384
Vera M. R. Heydendael Netherlands 9 493 1.2× 280 1.4× 99 0.8× 87 0.8× 102 1.1× 10 642
Ziqian Geng United States 9 706 1.8× 552 2.7× 137 1.1× 70 0.7× 108 1.2× 14 1.1k
P.P.M. van Lümig Netherlands 15 497 1.2× 297 1.5× 123 1.0× 131 1.2× 66 0.7× 18 605
D. Vidal Spain 12 371 0.9× 236 1.2× 125 1.0× 32 0.3× 100 1.1× 42 497

Countries citing papers authored by J.M. Carrascosa

Since Specialization
Citations

This map shows the geographic impact of J.M. Carrascosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Carrascosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Carrascosa more than expected).

Fields of papers citing papers by J.M. Carrascosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Carrascosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Carrascosa. The network helps show where J.M. Carrascosa may publish in the future.

Co-authorship network of co-authors of J.M. Carrascosa

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Carrascosa. A scholar is included among the top collaborators of J.M. Carrascosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Carrascosa. J.M. Carrascosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Belinchón, I., P. de la Cueva, Yolanda Gilaberte, et al.. (2023). Proyecto CUDERMA: Consenso Delphi de los indicadores de calidad para la certificación de las unidades de dermatología de atención en psoriasis. Actas Dermo-Sifiliográficas. 114(10). 865–883. 1 indexed citations
4.
Pinter, Andreas, Antonio Costanzo, Sanjay Khattri, et al.. (2023). Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and Therapy. 14(6). 1479–1493. 8 indexed citations
5.
Sher, Ellen, Mark Boguniewicz, Jinglin Zhong, et al.. (2023). Efficacy of Lebrikizumab in Patients With Atopic Dermatitis and Atopic Comorbidities: Pooled Results From Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-Week Studies (ADvocate1 and ADvocate2). Journal of Allergy and Clinical Immunology. 151(2). AB148–AB148. 2 indexed citations
6.
Carrascosa, J.M., et al.. (2022). Epidemia de escabiosis: los nuevos retos de una enfermedad ancestral. Actas Dermo-Sifiliográficas. 114(2). 132–140. 6 indexed citations
7.
Munera‐Campos, Mónica, et al.. (2021). Prevalence and stages of chronic kidney disease in psoriasis and psoriatic arthritis: A cross-sectional study. Indian Journal of Dermatology Venereology and Leprology. 87(2). 321–321. 5 indexed citations
8.
Puig, L., J.M. Carrascosa, & J. Notario. (2020). Biosimilares en el tratamiento de la psoriasis. Actualización. Actas Dermo-Sifiliográficas. 111(10). 809–814. 6 indexed citations
9.
Reich, Kristian, et al.. (2020). 13677 Time to relapse in patients with moderate to severe psoriasis who were tildrakizumab responders at week 28: Post hoc analysis through 64 weeks from the reSURFACE 1 trial. Journal of the American Academy of Dermatology. 83(6). AB11–AB11. 1 indexed citations
10.
Carrascosa, J.M., et al.. (2020). Apremilast for psoriasis treatment. Giornale Italiano di Dermatologia e Venereologia. 155(4). 421–433. 16 indexed citations
11.
Muñoz‐Torres, Manuel, P. Aguado, E. Daudén, J.M. Carrascosa, & R. Rivera. (2019). Osteoporosis and Psoriasis. Actas Dermo-Sifiliográficas. 110(8). 642–652. 10 indexed citations
12.
13.
Munera‐Campos, Mónica, et al.. (2018). Reacciones paradójicas de los tratamientos biológicos utilizados en psoriasis: revisión de la literatura. Actas Dermo-Sifiliográficas. 109(9). 791–800. 29 indexed citations
14.
Belinchón, I., José Manuel Ramos, G. Carretero, et al.. (2017). Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate‐to‐severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm. Journal of the European Academy of Dermatology and Venereology. 31(10). 1700–1708. 18 indexed citations
15.
González‐Parra, Emilio, E. Daudén, J.M. Carrascosa, et al.. (2016). Enfermedad renal y psoriasis. ¿Una nueva comorbilidad?. Actas Dermo-Sifiliográficas. 107(10). 823–829. 11 indexed citations
16.
Carrascosa, J.M., P. de la Cueva, M. Ara, et al.. (2015). Metotrexato en psoriasis moderada-grave: revisión de la literatura y recomendaciones de experto. Actas Dermo-Sifiliográficas. 107(3). 194–206. 34 indexed citations
17.
Carretero-Iglesia, Laura, Aram Boada, Roger Colobrán, et al.. (2011). CCL4L Polymorphisms and CCL4/CCL4L Serum Levels Are Associated with Psoriasis Severity. Journal of Investigative Dermatology. 131(9). 1830–1837. 28 indexed citations
18.
Rivera, R., I. García‐Doval, G. Carretero, et al.. (2011). BIOBADADERM: registro español de acontecimientos adversos de terapias biológicas en Dermatología. Primer informe. Actas Dermo-Sifiliográficas. 102(2). 132–141. 27 indexed citations
19.
Carrascosa, J.M.. (2008). Estrategias para optimizar el tratamiento con efalizumab. Actas Dermo-Sifiliográficas. 99. 37–50. 5 indexed citations
20.
Carrascosa, J.M., et al.. (1997). Sequential Combined Therapy with Thaiidomide and Narrow-Band (TL01) UVB in the Treatment of Prurigo nodularis. Dermatology. 195(4). 359–361. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.L.A. Kuijpers Breakdown of academic impact, for papers by X. Bordas Breakdown of academic impact, for papers by Eva Vilarrasa Breakdown of academic impact, for papers by M.A.M. Berends Breakdown of academic impact, for papers by J.L. Sánchez‐Carazo Breakdown of academic impact, for papers by Ting‐Shun Wang Breakdown of academic impact, for papers by Vera M. R. Heydendael Breakdown of academic impact, for papers by Ziqian Geng Breakdown of academic impact, for papers by P.P.M. van Lümig Breakdown of academic impact, for papers by D. Vidal
Rankless by CCL
2026